Effect of Ketorolac versus Nefopam after Laparoscopic Supracervical Hysterectomy

Effect of Ketorolac versus Nefopam Combined With Fentanyl-based Intravenous Patient-Controlled Analgesia after Laparoscopic Supracervical Hysterectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006475

Enrollment

180

Registered

2021-08-20

Start date

2020-02-17

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients were randomly divided into a group using Ketorolac and Nefopam. At the end of surgery, in the Ketorolac group, 1000 µg of fentanyl, 150 mg of ketorolac, and 0.6 mg of ramosetron were m

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The adult patients were between the ages of 20 and 65 years, with American Society of Anesthesiologists (ASA) physical status of 1 or 2, and had requested postoperative IV-PCA for laparoscopic gynecologic surgery scheduled to be performed at our hospital.

Exclusion criteria

Exclusion criteria: Patients with bleeding tendency, liver or kidney disease, taking sedatives or habitual drugs, mental disorders, and patients who are not suitable for the use of intravenous self-pain control devices are excluded.

Design outcomes

Primary

Measure	Time frame
postoperative nausea and vomiting	—

Secondary

Measure	Time frame
the quantity of analgesics used by each patient, the administration of additional analgesics, background infusion rate, Numerical rating scale, the sedation level, and other side effects	—

Countries

Korea, Republic of

Contacts

Public ContactNAN SEOL KIM

Soon Chun Hyang University Hospital Cheonan

nskim1977@naver.com+82-41-570-2829

Outcome results